Green Aaron purchased $21K of ONMD
Green Aaron (Chief Executive Officer) purchased 36,650 shares of OneMedNet Corp (ONMD) at $0.57 on 2026-06-23.
How this was made
The 30-second read
Why it matters
The newest fact is the CEO’s open-market purchase details (shares, price, total value, and post-transaction holdings). This can slightly influence sentiment but does not introduce new company fundamentals.
Market read
Traders may note the CEO buy as a small positive signal, but it is unlikely to drive a sustained repricing without additional fundamental news.
What to watch
No 10b5-1 plan is cited, but the filing also provides no rationale, no subsequent purchases, and no linkage to upcoming catalysts (earnings, trials, contracts).
Background
The article is an SEC Form 4 insider transaction disclosure for OneMedNet (ONMD).
Ticker impact
OneMedNet CEO Green Aaron filed an open-market purchase of 36,650 shares at $0.5733 on 2026-06-23 (Form 4).
Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.
The filing is primary-source (Form 4) and directly tied to ONMD, but the transaction size (~$21k) is not typically market-moving and no new operating/financial catalyst is disclosed.
Market effects
No clear sector read-through; this is a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Insider buys can be routine liquidity/portfolio rebalancing and may not reflect a change in fundamentals, especially without a larger follow-through pattern.
Key entities
- issuerOneMedNet Corp
Subject of the Form 4 insider transaction disclosure.
- insiderGreen Aaron
CEO and director who purchased shares in an open-market transaction.
